These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1613746)

  • 1. Synthesis and muscarinic receptor activity of ester derivatives of 2-substituted 2-azabicyclo[2.2.1]heptan-5-ol and -6-ol.
    Carroll FI; Abraham P; Chemburkar S; He XC; Mascarella SW; Kwon YW; Triggle DJ
    J Med Chem; 1992 Jun; 35(12):2184-91. PubMed ID: 1613746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
    Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
    Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues.
    Triggle DJ; Kwon YW; Abraham P; Pitner JB; Mascarella SW; Carroll FI
    J Med Chem; 1991 Nov; 34(11):3164-71. PubMed ID: 1956033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SAR of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists.
    Tecle H; Lauffer DJ; Mirzadegan T; Moos WH; Moreland DW; Pavia MR; Schwarz RD; Davis RE
    Life Sci; 1993; 52(5-6):505-11. PubMed ID: 8382765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).
    Leader H; Gordon RK; Baumgold J; Boyd VL; Newman AH; Smejkal RM; Chiang PK
    J Med Chem; 1992 Apr; 35(7):1290-5. PubMed ID: 1560441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
    Daly JW; Gupta TH; Padgett WL; Pei XF
    J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.
    Messer WS; Ellerbrock BR; Smith DA; Hoss W
    J Med Chem; 1989 Jun; 32(6):1164-72. PubMed ID: 2724292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
    Rzeszotarski WJ; McPherson DW; Ferkany JW; Kinnier WJ; Noronha-Blob L; Kirkien-Rzeszotarski A
    J Med Chem; 1988 Jul; 31(7):1463-6. PubMed ID: 3385735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives.
    Wadsworth HJ; Jenkins SM; Orlek BS; Cassidy F; Clark MS; Brown F; Riley GJ; Graves D; Hawkins J; Naylor CB
    J Med Chem; 1992 Apr; 35(7):1280-90. PubMed ID: 1560440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
    Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
    Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
    Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines .
    Sauerberg P; Olesen PH; Nielsen S; Treppendahl S; Sheardown MJ; Honoré T; Mitch CH; Ward JS; Pike AJ; Bymaster FP
    J Med Chem; 1992 Jun; 35(12):2274-83. PubMed ID: 1613751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor binding and activation of second messengers by substituted N-methyl-N-[4-(1-azacycloalkyl)-2-butynyl]acetamides.
    Bradbury BJ; Baumgold J; Paek R; Kammula U; Zimmet J; Jacobson KA
    J Med Chem; 1991 Mar; 34(3):1073-9. PubMed ID: 1848294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and In vitro binding affinities of 1-azabicyclic compounds as muscarinic ligands.
    Cha JH; Cho YS; Pae AN; Koh HY; Jeong D; Kong JY; Lee E; Choi KI
    Bioorg Med Chem Lett; 2001 Nov; 11(21):2855-7. PubMed ID: 11597415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activity of the M1-M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    FEBS Lett; 1995 Dec; 377(2):275-9. PubMed ID: 8543067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists and agonists interactions with the muscarinic receptor of the rat large airways.
    Scott T; McMahon KK
    J Pharmacol Exp Ther; 1988 Oct; 247(1):136-42. PubMed ID: 3171971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
    Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
    Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.